Hyperhomocysteinemia is Associated with Aortic Atheroma Progression in Stroke/TIA Patients

Souvik Sen1, P Leema Reddy, Raji P Grewal

  • 1Department of Neurology, University of South Carolina School of Medicine Columbia, SC, USA.

Frontiers in Neurology
|December 29, 2010
PubMed

Insights

Elevated total homocysteine levels (tHcy) are linked to aortic arch atheroma progression in stroke patients. This study confirms a significant association between higher tHcy and increased risk of aortic arch plaque advancement over one year.

Area of Science:

  • Cardiovascular Medicine
  • Neurology
  • Atherosclerosis Research

Background:

  • Aortic arch (AA) atheroma and its progression are established risk factors for recurrent vascular events in patients with stroke or transient ischemic attack (TIA).
  • Elevated total homocysteine (tHcy) levels are recognized as an independent risk marker for atherosclerosis, including within the aortic arch.

Purpose of the Study:

  • To prospectively investigate the association between the progression of aortic arch atheroma and total homocysteine levels in stroke/TIA patients.

Main Methods:

  • A cohort study involving 118 stroke/TIA patients with measurable AA atheroma and available tHcy data.
  • Follow-up transesophageal echocardiograms (TEE) were performed at 12 months to assess AA atheroma progression (defined as ≥1 grade increase).
  • Evaluations included vascular risk factors, dietary intake (folate, B12, pyridoxine), and MTHFR polymorphism.

Main Results:

  • A significant association was found between elevated tHcy (≥14.0 μmol/l) and AA atheroma progression (univariate RR=3.4, adjusted RR=3.6).
  • Changes in AA plaque thickness and area correlated with tHcy levels.
  • tHcy independently predicted changes in plaque thickness over 12 months, irrespective of other factors.

Conclusions:

  • The study validates a significant association between total homocysteine levels and the progression of aortic arch atheroma.
  • A linear correlation exists between tHcy and the advancement of AA atheroma, highlighting tHcy as a key marker.
Abstract

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...